Location History:
- Niterói, BR (2014)
- Niteroi, BR (2001 - 2019)
Company Filing History:
2 out of 32 
1 out of 1 
2 out of 832,961 Years Active: 2001-2019
Title: The Innovations of Ricardo Galler in Recombinant Virus Technology
Introduction
Ricardo Galler, a notable inventor located in Niteroi, Brazil, has made significant contributions in the field of biotechnology. With a total of five patents to his name, Galler's work primarily focuses on the production of recombinant viruses and their application in vaccine development. His innovative methods are paving the way for advanced immunization techniques against various pathogens.
Latest Patents
Galler's latest patents include groundbreaking methodologies for the production of recombinant viruses, DNA constructs, and vaccine compositions aimed at immunizing against Flavivirus and other infectious agents. The core of his inventions lies in the cloning and expression of sequences encoding heterologous proteins. His method involves the modification of nucleotide sequences to create non-pathogenic recombinant viruses with integrated heterologous sequences, designed to elicit appropriate immune responses in hosts.
Career Highlights
Throughout his career, Ricardo Galler has worked with esteemed institutions such as the Fundação Oswaldo Cruz (Fiocruz), where he has furthered his research and innovation in the field of virology and immunology. His dedication to advancing scientific knowledge has not only contributed to his success as an inventor but also to the broader field of medicine and public health.
Collaborations
Galler's work has often involved collaboration with other esteemed professionals in the field. Notable collaborators include Myrna Cristina Bonaldo and Marcos Da Silva Freire, who have contributed to his research initiatives, enhancing the depth and scope of his innovative projects. These collaborations have fostered a rich environment for scientific discovery and technological advancement.
Conclusion
Ricardo Galler stands out as a prolific inventor whose contributions to recombinant virus technology are making a significant impact on vaccine development. His patents represent a critical advancement in the field, highlighting the importance of innovation in addressing public health challenges. As he continues to work and collaborate with fellow researchers, Galler's influence on biotechnology is poised to grow, further shaping the future of immunization strategies.